Clinical trial · Observational
Implementation of a Pharmacist-Based, Post-Chemotherapy Follow-up Clinic
NCT05965206CI-TRIAL-00089629completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the impact of pharmacists on reducing chemotherapy-related side effects by providing education before and after patients receive intravenous chemotherapy at one of Cedars-Sinai outpatient infusion centers. Participants will be interviewed via telephone within 7 business days after receiving intravenous chemotherapy from the outpatient cancer center infusion clinic.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Follow-up phone interview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Intervention group
- description
- Participants receive a follow-up phone call from a pharmacist approximately 7 business days after receiving intravenous chemotherapy infusion
- interventionNames
- Behavioral: Follow-up phone interview
- label
- Control group
- description
- Participants do not receive a follow-up phone call from a pharmacist after receiving intravenous chemotherapy infusion
Primary outcomes (1)
- measure
- Hospital admission related to chemotherapy within 30-day post treatment
- timeFrame
- 30 days after receiving the first intravenous chemotherapy
- description
- Number of hospital admission related to chemotherapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * At least 18 years old * Diagnosed with cancer and is receiving treatment with intravenous chemotherapy * Treatment initiated at Cedars-Sinai Cancer Samuel Oschin Cancer Center (SOCC) or Cedars-Sinai Cancer Beverly Hills (CSCBH) * English-speaking or lives with English-speaking person * Access to a working phone Exclusion Criteria: * Received follow-up calls through other specialty pharmacy program * History of infusion related reactions * Declined participation on follow-up interview * Age less than 18 years old * Non-English speaking * Electronic health record flagged for research opt out
References
Publications (4)
- BACKGROUNDPatel SD, Nguyen PAA, Bachler M, Atkinson B. Implementation of postdischarge follow-up telephone calls at a comprehensive cancer center. Am J Health Syst Pharm. 2017 Jun 1;74(11 Supplement 2):S42-S46. doi: 10.2146/ajhp160805. PMID 28506976
- BACKGROUNDNguyen PAA, Enwere E, Gautreaux S, Lin H, Tverdek F, Lu M, Cao H, Chase J, Roux R. Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center. Am J Health Syst Pharm. 2018 Sep 15;75(18):1386-1393. doi: 10.2146/ajhp170747. Epub 2018 Jul 31. PMID 30065061
- RESULTCebollero J, LaFollette JA, Walton SM, Adams Curry M. Evaluation of a Pharmacist-Developed, Nurse-Driven Protocol for Management of Parenteral Anticancer Therapy Infusion Reactions in an Ambulatory Infusion Center. J Oncol Pharm Pract. 2023 Jun;29(4):802-809. doi: 10.1177/10781552221079855. Epub 2022 Feb 14. PMID 35164607
- RESULTCrannage AJ, Hennessey EK, Challen LM, Stevens AM, Berry TM. Implementation of a Discharge Education Program to Improve Transitions of Care for Patients at High Risk of Medication Errors. Ann Pharmacother. 2020 Jun;54(6):561-566. doi: 10.1177/1060028019896377. Epub 2019 Dec 21. PMID 31868004